Item 9B. OTHER INFORMATION
2K characters. Original on sec.gov ·
Item 9B. OTHER INFORMATION
Effective February 21, 2022, our board of directors promoted Kaes Van’t Hof, then our Chief Financial Officer and Executive Vice President—Business Development to the role of our President. In addition to his role as our President, Mr. Van’t Hof will continue to serve as our Chief Financial Officer. Also, effective February 21, 2022, our board of directors promoted Daniel N. Wesson, then our Executive Vice President—Operations, to the role of our Chief Operating Officer. In addition to his role as our Chief Operating Officer, Mr. Wesson will continue to serve as our Executive Vice President.
Mr. Van’t Hof’s and Mr. Wesson’s full biographies and, to the extent applicable, the information required by Item 404(a) of Regulation S-K, are included in our definitive proxy statement on Schedule 14A, filed by us with the SEC on April 23, 2021, which we refer to as our 2021 proxy statement. Each of Mr. Van’t Hof and Mr. Wesson was named as our named executive officer in our 2021 proxy statement.
In connection with these promotions, the compensation committee of our board of directors approved increases in Mr. Van’t Hof’s and Mr. Wesson’s annual base salaries to $625,000 and $560,000, respectively. In addition, the compensation committee also approved annual long-term equity incentive compensation awards with an intended grant date value of $3,750,000 for Mr. Van’t Hof and $2,250,000 for Mr. Wesson to be granted under our equity incentive plan and represented by a combination of performance-based and time-based restricted stock units, vesting over applicable performance or service periods.
These executives will continue to participate in our annual executive cash incentive plan, which provides an opportunity to receive an annual bonus payable in a single lump sum, based on a target percentage of these executives’ respective annual base salaries and such performance goals and criteria as determined in the discretion of the compensation committee of our board of directors, as well as in other employee benefit plans generally available to similarly situated employees, as in effect from time to time, a description of which is included in our 2021 proxy statement.
Previous: Item 9A. CONTROLS AND PROCEDURES · Next: Item 9C. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS